CIK 0001806952
- Non-accelerated filer
- Smaller reporting company
Lyell Immunopharma, Inc.
Sign in to watch- Ticker
- LYEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833006753
- Phone
- +1 650-695-0677
- Business address
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $49,999,983
- in 2 filings
- Open-market sales, last 90 days
- $28,757
- in 6 filings
Net +$49,971,226. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-10 | Shook David Chief Medical Officer | Sale | −500 | $12.70 | $6K | 20,423 |
| 2026-06-10 | Shook David Chief Medical Officer | Sale | −1,977 | $12.64 | $25K | 20,923 |
| 2026-02-10 | Shook David Chief Medical Officer | Grant or award · Option (right to buy) | +50,000 | 50,000 | ||
| 2025-06-09 | Shook David Chief Medical Officer | Grant or award | +21,900 | 21,900 | ||
| 2025-06-09 | Shook David Chief Medical Officer | Grant or award · Option (right to buy) | +43,750 | 43,750 |
Page 1 of 1 · 5 trades